AU2021362248A1 - Modified release softgel capsules - Google Patents

Modified release softgel capsules Download PDF

Info

Publication number
AU2021362248A1
AU2021362248A1 AU2021362248A AU2021362248A AU2021362248A1 AU 2021362248 A1 AU2021362248 A1 AU 2021362248A1 AU 2021362248 A AU2021362248 A AU 2021362248A AU 2021362248 A AU2021362248 A AU 2021362248A AU 2021362248 A1 AU2021362248 A1 AU 2021362248A1
Authority
AU
Australia
Prior art keywords
modified release
softgel capsule
composition
controlled release
dependent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021362248A
Other languages
English (en)
Other versions
AU2021362248A9 (en
Inventor
Qi Fang
Karunakar Sukuru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Publication of AU2021362248A1 publication Critical patent/AU2021362248A1/en
Publication of AU2021362248A9 publication Critical patent/AU2021362248A9/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2021362248A 2020-10-16 2021-10-15 Modified release softgel capsules Pending AU2021362248A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063092762P 2020-10-16 2020-10-16
US63/092,762 2020-10-16
PCT/US2021/071900 WO2022082222A1 (en) 2020-10-16 2021-10-15 Modified release softgel capsules

Publications (2)

Publication Number Publication Date
AU2021362248A1 true AU2021362248A1 (en) 2023-06-01
AU2021362248A9 AU2021362248A9 (en) 2024-05-02

Family

ID=81208677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021362248A Pending AU2021362248A1 (en) 2020-10-16 2021-10-15 Modified release softgel capsules

Country Status (14)

Country Link
US (1) US20230390210A1 (https=)
EP (1) EP4228597A4 (https=)
JP (1) JP2023547062A (https=)
KR (1) KR20230088388A (https=)
CN (1) CN116322655A (https=)
AR (1) AR123805A1 (https=)
AU (1) AU2021362248A1 (https=)
BR (1) BR112023006154A2 (https=)
CA (1) CA3194160A1 (https=)
CO (1) CO2023005753A2 (https=)
IL (1) IL301715A (https=)
MX (1) MX2023004418A (https=)
TW (1) TW202228656A (https=)
WO (1) WO2022082222A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025135085A1 (ja) * 2023-12-22 2025-06-26 花王株式会社 カプセル剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US7842307B2 (en) * 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
KR20100047349A (ko) * 2001-11-22 2010-05-07 모리시타 진탄 가부시키가이샤 비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐
KR100575199B1 (ko) * 2003-01-24 2006-05-02 알앤피코리아주식회사 연질 캡슐의 블루밍 방지를 위한 가소제 조성물 및 이를함유한 피막
IT1401313B1 (it) * 2010-08-05 2013-07-18 Perfetti Van Melle Spa Caramelle gelatinose con ripieno fluido e metodo di ottenimento
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
US20210353574A1 (en) * 2018-10-16 2021-11-18 Bayer Healthcare Llc Softgels with solid or gel-like polymeric fill matrix
MX2022005050A (es) * 2019-10-28 2022-07-04 Scherer Technologies Llc R P Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto.

Also Published As

Publication number Publication date
CO2023005753A2 (es) 2023-05-29
EP4228597A4 (en) 2024-10-02
MX2023004418A (es) 2023-05-04
TW202228656A (zh) 2022-08-01
US20230390210A1 (en) 2023-12-07
CN116322655A (zh) 2023-06-23
KR20230088388A (ko) 2023-06-19
CA3194160A1 (en) 2022-04-21
AR123805A1 (es) 2023-01-11
WO2022082222A1 (en) 2022-04-21
JP2023547062A (ja) 2023-11-09
BR112023006154A2 (pt) 2023-05-09
IL301715A (en) 2023-05-01
AU2021362248A9 (en) 2024-05-02
EP4228597A1 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
US10632113B2 (en) Abuse-resistant drug formulations with built-in overdose protection
AU2005309406A1 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
EP3976022A1 (en) Delayed release softgel capsules
AU2020363824B2 (en) Non-animal softgel capsule formulations, methods of preparation, and methods of use thereof
EP4051016A1 (en) Delayed release softgel capsules in higher ph environment
AU2026201700A1 (en) Controlled release fill compositions and capsules containing same
US20230390210A1 (en) Modified release softgel capsules
EP4156971A1 (en) Delayed release softgel capsules
AU2012201450A1 (en) Methods and compositions for deterring abuse of orally administered pharmaceutical products
HK40095991A (zh) 调节释放软凝胶胶囊
HK40090240A (zh) 控释填料组合物和含有该组合物的胶囊
JP2009501796A (ja) 睡眠薬の放出調整
CN120282775A (zh) 软凝胶胶囊和制备软凝胶胶囊的方法

Legal Events

Date Code Title Description
SREP Specification republished